Cetera Investment Advisers
DERM icon

Cetera Investment Advisers’s Journey Medical DERM Stock Holding History

Cetera Investment Advisers’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,225
Closed -$48K – 5055
2026
Q1 		$48K Buy
+10,225
New +$79.4K ﹤0.01% 4586
2025
Q3 		– Sell
-10,731
Closed -$77K – 4591
2025
Q2 		$77K Sell
10,731
-4,418
-29% -$30.5K ﹤0.01% 3922
2025
Q1 		$89.4K Buy
15,149
+1,310
+9% +$6.44K ﹤0.01% 3795
2024
Q4 		$54.1K Buy
13,839
+2,478
+22% +$13.5K ﹤0.01% 3651
2024
Q3 		$64.2K Sell
11,361
-7,252
-39% -$37.3K ﹤0.01% 3583
2024
Q2 		$105K Buy
+18,613
New +$76.6K ﹤0.01% 3508

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Cetera Investment Advisers's DERM Position: Q2 2026 in Review

Cetera Investment Advisers sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 10,225 shares — an estimated $48K sold.

Cetera Investment Advisers first reported a position in DERM in Q2 2024 and held it in 6 quarters. The position peaked at $105K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Cetera Investment Advisers reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 10,225 Journey Medical shares in Q2 2026, an estimated $48K.
  • Cetera Investment Advisers first reported a position in Journey Medical in Q2 2024 and held it in 6 quarters.
  • Cetera Investment Advisers's Journey Medical position peaked at $105K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.